Anti-epidermal growth factor receptor (EGFR) monoclonal antibody combined with cisplatin and 5-fluorouracil in patients with metastatic nasopharyngeal carcinoma after radical radiotherapy: a multicentre, open-label, phase II clinical trial
Autor: | Zhao, C., Miao, J., Shen, G., Li, J., Shi, M., Zhang, N., Hu, G., Chen, X., Hu, X., Wu, S., Chen, J., Shao, X., Wang, L., Han, F., Mai, H., Chua, M.L.K. *, Xie, C. * |
---|---|
Zdroj: | In Annals of Oncology April 2019 30(4):637-643 |
Databáze: | ScienceDirect |
Externí odkaz: |